The U.K. economy grew by 0.6 percent in the second-quarter of the year, quarter-on-quarter, according to the first official estimate out since the country's Brexit vote stunned global markets. » Read More
Get the best of CNBC in your inbox
Andrew Witty, CEO of GlaxoSmithKline, says the firm has been investing in bio electronic medicine for the last few years.
Andrew Witty, CEO of GlaxoSmithKline, explains why he was opposed to Brexit but adds that everything is now business as usual at the company.
Andrew Witty, CEO of GlaxoSmithKline, comments on the company's earnings which beat expectations, with sales up 11 percent.